
Publication
Essential UK Pensions News
Essential UK Pensions News covers the key pensions developments each month.
We use cookies and other similar technology to collect data about you to allow us to deliver our online services, measure our website audience and improve your browsing experience. Full details on the cookies we use are set out in our Cookies policy. Please click OK to signify your consent to our use of cookies.
You can withdraw your consent by clicking “manage cookies” and following the instructions shown.
Global | Publication | April 2018
The US Food and Drug Administration does not have much of a sense of humor when it comes to the mandatory ingredient list on packaged food products. Last month, the FDA issued a Warning Letter to the Nashoba Brook Bakery in Concord, Massachusetts, for, among other violations, listing “love” as an ingredient in its granola and whole wheat bread, in violation of 21 C.F.R. § 101.4(a)(1), which requires the label or labelling of a food to display a list of ingredients, “listed by common or usual name in descending order of predominance by weight on either the principal display panel or the information panel.” According to the FDA:
“‘Love’ is not a common or usual name of an ingredient, and is considered to be intervening material because it is not part of the common or usual name of the ingredient.”
Accordingly, it concluded that the products were misbranded under 21 U.S.C. § 343(i)(2), which sets forth the ingredient listing requirement.
It does not appear, however, that the FDA targeted this bakery solely for its creative labelling: an FDA inspection earlier this year found numerous serious violations of the Current Good Manufacturing Practice regulations, including failure to clean and sanitize equipment, staff wearing jewelry while working in direct contact with food, and “[o]ne approximately one inch long crawling insect underneath exposed ready-to-eat foods in the pastry area,” as well as other labelling violations. After being issued a listing of the FDA’s inspectional observations (FDA Form 483), the bakery provided no formal response to the FDA, triggering the Warning Letter.
This case serves as a warning that food companies should avoid creative license with ingredient lists, even when the reasonable consumer would clearly not expect the “ingredient”—in this case, love—to be in the product.
Publication
Essential UK Pensions News covers the key pensions developments each month.
Publication
An enduring merger control trend is the authorities’ greater focus on parties’ internal documents, and the related risk of penalties and delays to reviews where parties fail to submit complete responses to RFIs or provide incomplete or misleading submissions.
Publication
An increasing challenge for M&A parties is identifying where their deals will be reviewed in a context where merger control authorities are finding new ways to take jurisdiction over transactions falling below traditional (usually turnover-based) notification thresholds
Subscribe and stay up to date with the latest legal news, information and events...
© Norton Rose Fulbright LLP 2023